Former Congressmen Leading Charge Against Alzheimer's
Former Speaker of the House Newt Gingrich and former U.S. Senator Bob Kerrey, co-chairs of the Alzheimer's Study Group (ASG), announced the full membership of the taskforce they have assembled to develop and advance strategies to overcome Alzheimer's.
Other members include:
- Christine Cassel, M.D., Geriatrician and President, American Board of Internal Medicine
- Meryl Comer, President, Geoffrey Beane Foundation Alzheimer's Initiative
- Newt Gingrich , Founder, Center for Health Transformation
- Steven Hyman, M.D., Provost, Harvard University
- Bob Kerrey, President, The New School
- Henry McCance Chairman, Greylock Partners
- Mark McClellan, M.D., Ph.D., Director, Engelberg Center for Health Care Reform, Brookings Institution
- Sandra Day O'Connor, Justice, The US Supreme Court (retired)
- James Runde, Special Advisor, Morgan Stanley
- David Satcher, M.D., Director, Center of Excellence on Health Disparities, Morehouse School of Medicine
- Harold Varmus, M.D. , President, Memorial Sloan-Kettering Cancer Center
The team will engage with leading Alzheimer's experts nationwide to understand how we can accelerate the development of new treatments and provide better care to those 5 million Americans already battling the disease, Kerrey said in a press release.
The ASG's mission is to assess the adequacy of the country's current effrots to combat Alzheimer's and recommend a National Alzheimer's Strategic Plan some time in mid-2008.
With leaders of this magnitude involved, hopefully it will bring positive results for those living with Alzheimer's and their caregivers.
For more information, visit the ASG's Web site.